Structure

Physi-Chem Properties

Molecular Weight:  398.25
Volume:  440.549
LogP:  4.555
LogD:  4.307
LogS:  -4.923
# Rotatable Bonds:  11
TPSA:  66.74
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.315
Synthetic Accessibility Score:  4.094
Fsp3:  0.44
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.749
MDCK Permeability:  2.708600732148625e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.063
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.023
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.031
Plasma Protein Binding (PPB):  99.63579559326172%
Volume Distribution (VD):  3.023
Pgp-substrate:  0.8083695769309998%

ADMET: Metabolism

CYP1A2-inhibitor:  0.343
CYP1A2-substrate:  0.834
CYP2C19-inhibitor:  0.783
CYP2C19-substrate:  0.176
CYP2C9-inhibitor:  0.831
CYP2C9-substrate:  0.983
CYP2D6-inhibitor:  0.868
CYP2D6-substrate:  0.915
CYP3A4-inhibitor:  0.727
CYP3A4-substrate:  0.259

ADMET: Excretion

Clearance (CL):  8.882
Half-life (T1/2):  0.796

ADMET: Toxicity

hERG Blockers:  0.011
Human Hepatotoxicity (H-HT):  0.762
Drug-inuced Liver Injury (DILI):  0.912
AMES Toxicity:  0.011
Rat Oral Acute Toxicity:  0.851
Maximum Recommended Daily Dose:  0.563
Skin Sensitization:  0.4
Carcinogencity:  0.851
Eye Corrosion:  0.003
Eye Irritation:  0.06
Respiratory Toxicity:  0.97

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC81912

Natural Product ID:  NPC81912
Common Name*:   Epi-Sarcotin A
IUPAC Name:   (2R)-2-[(2Z,6S,7E,9E)-13-(furan-3-yl)-2,6,10-trimethyltrideca-2,7,9-trienyl]-3-hydroxy-4-methyl-2H-furan-5-one
Synonyms:  
Standard InCHIKey:  UXFNAATUJSSAHF-CNGQNWGCSA-N
Standard InCHI:  InChI=1S/C25H34O4/c1-18(8-5-9-19(2)11-7-13-22-14-15-28-17-22)10-6-12-20(3)16-23-24(26)21(4)25(27)29-23/h5,8-9,12,14-15,17-18,23,26H,6-7,10-11,13,16H2,1-4H3/b8-5+,19-9+,20-12-/t18-,23-/m1/s1
SMILES:  C[C@H](/C=C/C=C(C)/CCCc1ccoc1)CC/C=C(/C)C[C@@H]1C(=C(C)C(=O)O1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL482611
PubChem CID:   54718147
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33064 sarcotragus sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[11678655]
NPO33064 sarcotragus sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[12350153]
NPO33064 sarcotragus sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[18341287]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 = 12.3 ug ml-1 PMID[545397]
NPT146 Cell Line SK-OV-3 Homo sapiens ED50 = 9.6 ug ml-1 PMID[545397]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 = 5.6 ug ml-1 PMID[545397]
NPT574 Cell Line XF498 Homo sapiens ED50 = 9.8 ug ml-1 PMID[545397]
NPT148 Cell Line HCT-15 Homo sapiens ED50 = 6.5 ug ml-1 PMID[545397]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC81912 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC329922
1.0 High Similarity NPC329694
1.0 High Similarity NPC474260
0.975 High Similarity NPC476016
0.9748 High Similarity NPC75557
0.9748 High Similarity NPC71274
0.9746 High Similarity NPC475818
0.9669 High Similarity NPC474438
0.9669 High Similarity NPC474279
0.9587 High Similarity NPC474830
0.958 High Similarity NPC476351
0.9496 High Similarity NPC289911
0.9496 High Similarity NPC283284
0.9492 High Similarity NPC474817
0.9421 High Similarity NPC474829
0.9412 High Similarity NPC474136
0.9244 High Similarity NPC473969
0.9237 High Similarity NPC144745
0.9237 High Similarity NPC208906
0.9127 High Similarity NPC17681
0.9106 High Similarity NPC471559
0.9076 High Similarity NPC131801
0.9055 High Similarity NPC97740
0.896 High Similarity NPC471554
0.896 High Similarity NPC471573
0.896 High Similarity NPC473355
0.896 High Similarity NPC471501
0.8906 High Similarity NPC45358
0.8862 High Similarity NPC473379
0.8862 High Similarity NPC471549
0.8855 High Similarity NPC215109
0.8855 High Similarity NPC170604
0.8837 High Similarity NPC474426
0.8837 High Similarity NPC474425
0.8837 High Similarity NPC474407
0.881 High Similarity NPC137570
0.8729 High Similarity NPC105249
0.872 High Similarity NPC243269
0.8702 High Similarity NPC14650
0.8655 High Similarity NPC1811
0.8655 High Similarity NPC26157
0.8636 High Similarity NPC303217
0.8626 High Similarity NPC288209
0.848 Intermediate Similarity NPC1848
0.8475 Intermediate Similarity NPC473356
0.8475 Intermediate Similarity NPC471521
0.8468 Intermediate Similarity NPC4898
0.8444 Intermediate Similarity NPC107571
0.8443 Intermediate Similarity NPC28054
0.8438 Intermediate Similarity NPC138139
0.8438 Intermediate Similarity NPC46536
0.8425 Intermediate Similarity NPC188377
0.8425 Intermediate Similarity NPC118853
0.8425 Intermediate Similarity NPC65735
0.8413 Intermediate Similarity NPC477967
0.8397 Intermediate Similarity NPC89133
0.8387 Intermediate Similarity NPC21831
0.8387 Intermediate Similarity NPC187547
0.8372 Intermediate Similarity NPC83178
0.8333 Intermediate Similarity NPC471545
0.8333 Intermediate Similarity NPC471544
0.8333 Intermediate Similarity NPC473344
0.8308 Intermediate Similarity NPC112706
0.8308 Intermediate Similarity NPC207294
0.8296 Intermediate Similarity NPC473268
0.8284 Intermediate Similarity NPC159786
0.8273 Intermediate Similarity NPC218712
0.8273 Intermediate Similarity NPC267004
0.8273 Intermediate Similarity NPC261733
0.8273 Intermediate Similarity NPC307346
0.8268 Intermediate Similarity NPC263870
0.825 Intermediate Similarity NPC177331
0.8217 Intermediate Similarity NPC179354
0.8203 Intermediate Similarity NPC16922
0.8195 Intermediate Similarity NPC471817
0.8195 Intermediate Similarity NPC473982
0.8189 Intermediate Similarity NPC79557
0.8175 Intermediate Similarity NPC90953
0.816 Intermediate Similarity NPC217180
0.816 Intermediate Similarity NPC312525
0.8156 Intermediate Similarity NPC104924
0.8148 Intermediate Similarity NPC476947
0.814 Intermediate Similarity NPC477038
0.814 Intermediate Similarity NPC477965
0.8134 Intermediate Similarity NPC218838
0.8125 Intermediate Similarity NPC317217
0.812 Intermediate Similarity NPC298190
0.812 Intermediate Similarity NPC136340
0.8112 Intermediate Similarity NPC234494
0.8095 Intermediate Similarity NPC243704
0.8095 Intermediate Similarity NPC291619
0.8095 Intermediate Similarity NPC254958
0.8092 Intermediate Similarity NPC95567
0.8092 Intermediate Similarity NPC319140
0.808 Intermediate Similarity NPC45536
0.8071 Intermediate Similarity NPC254198
0.8071 Intermediate Similarity NPC80635
0.8029 Intermediate Similarity NPC186626
0.8016 Intermediate Similarity NPC227660
0.8015 Intermediate Similarity NPC74612
0.8015 Intermediate Similarity NPC23086
0.8015 Intermediate Similarity NPC92941
0.8 Intermediate Similarity NPC150895
0.8 Intermediate Similarity NPC205523
0.8 Intermediate Similarity NPC121158
0.8 Intermediate Similarity NPC470740
0.7986 Intermediate Similarity NPC125182
0.7986 Intermediate Similarity NPC69647
0.7985 Intermediate Similarity NPC61788
0.7972 Intermediate Similarity NPC255414
0.7958 Intermediate Similarity NPC34056
0.7956 Intermediate Similarity NPC146872
0.7945 Intermediate Similarity NPC33938
0.7945 Intermediate Similarity NPC121615
0.7945 Intermediate Similarity NPC294511
0.7943 Intermediate Similarity NPC267632
0.7941 Intermediate Similarity NPC106247
0.7937 Intermediate Similarity NPC476031
0.7937 Intermediate Similarity NPC476014
0.7931 Intermediate Similarity NPC470997
0.7917 Intermediate Similarity NPC7388
0.7914 Intermediate Similarity NPC202260
0.791 Intermediate Similarity NPC21460
0.7899 Intermediate Similarity NPC470742
0.7895 Intermediate Similarity NPC477123
0.7895 Intermediate Similarity NPC477039
0.7895 Intermediate Similarity NPC477040
0.7895 Intermediate Similarity NPC477966
0.7891 Intermediate Similarity NPC237259
0.7891 Intermediate Similarity NPC34421
0.7891 Intermediate Similarity NPC302054
0.7891 Intermediate Similarity NPC253201
0.7891 Intermediate Similarity NPC98206
0.7887 Intermediate Similarity NPC137295
0.7887 Intermediate Similarity NPC251865
0.7879 Intermediate Similarity NPC216810
0.7863 Intermediate Similarity NPC130275
0.7857 Intermediate Similarity NPC56197
0.7852 Intermediate Similarity NPC475092
0.7852 Intermediate Similarity NPC472778
0.7852 Intermediate Similarity NPC472776
0.7852 Intermediate Similarity NPC472777
0.7847 Intermediate Similarity NPC216755
0.7847 Intermediate Similarity NPC471174
0.7842 Intermediate Similarity NPC236532
0.7838 Intermediate Similarity NPC141538
0.7838 Intermediate Similarity NPC296807
0.7838 Intermediate Similarity NPC155939
0.7836 Intermediate Similarity NPC120836
0.7836 Intermediate Similarity NPC223063
0.7832 Intermediate Similarity NPC195920
0.7823 Intermediate Similarity NPC472672
0.7823 Intermediate Similarity NPC474219
0.7823 Intermediate Similarity NPC268905
0.7823 Intermediate Similarity NPC474378
0.7817 Intermediate Similarity NPC22248
0.7817 Intermediate Similarity NPC476946
0.7812 Intermediate Similarity NPC293424
0.7808 Intermediate Similarity NPC228842
0.7795 Intermediate Similarity NPC474987
0.7795 Intermediate Similarity NPC76844
0.7793 Intermediate Similarity NPC93666
0.7793 Intermediate Similarity NPC471007
0.7778 Intermediate Similarity NPC346
0.7778 Intermediate Similarity NPC476925
0.777 Intermediate Similarity NPC310830
0.7762 Intermediate Similarity NPC476944
0.7761 Intermediate Similarity NPC26532
0.7761 Intermediate Similarity NPC329707
0.7761 Intermediate Similarity NPC476917
0.7761 Intermediate Similarity NPC327527
0.7746 Intermediate Similarity NPC52412
0.774 Intermediate Similarity NPC472654
0.7733 Intermediate Similarity NPC197137
0.7733 Intermediate Similarity NPC194499
0.7733 Intermediate Similarity NPC88007
0.7733 Intermediate Similarity NPC7059
0.773 Intermediate Similarity NPC201370
0.773 Intermediate Similarity NPC282973
0.773 Intermediate Similarity NPC473983
0.773 Intermediate Similarity NPC67003
0.773 Intermediate Similarity NPC148374
0.7724 Intermediate Similarity NPC302987
0.7724 Intermediate Similarity NPC71821
0.7724 Intermediate Similarity NPC476937
0.7724 Intermediate Similarity NPC250228
0.7724 Intermediate Similarity NPC476938
0.7721 Intermediate Similarity NPC477645
0.7718 Intermediate Similarity NPC281258
0.7718 Intermediate Similarity NPC92979
0.7718 Intermediate Similarity NPC214541
0.7718 Intermediate Similarity NPC44675
0.7717 Intermediate Similarity NPC11821
0.7714 Intermediate Similarity NPC220094
0.7714 Intermediate Similarity NPC476943
0.771 Intermediate Similarity NPC36255
0.7708 Intermediate Similarity NPC5676
0.7704 Intermediate Similarity NPC198904
0.7704 Intermediate Similarity NPC208389
0.7703 Intermediate Similarity NPC147168

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC81912 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.766 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7554 Intermediate Similarity NPD6355 Discontinued
0.75 Intermediate Similarity NPD4628 Phase 3
0.7338 Intermediate Similarity NPD6798 Discontinued
0.7319 Intermediate Similarity NPD6832 Phase 2
0.7299 Intermediate Similarity NPD5647 Approved
0.7259 Intermediate Similarity NPD9717 Approved
0.7163 Intermediate Similarity NPD4062 Phase 3
0.7163 Intermediate Similarity NPD6233 Phase 2
0.7153 Intermediate Similarity NPD2799 Discontinued
0.7143 Intermediate Similarity NPD5760 Phase 2
0.7143 Intermediate Similarity NPD5761 Phase 2
0.7133 Intermediate Similarity NPD6653 Approved
0.7101 Intermediate Similarity NPD2797 Approved
0.7075 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7023 Intermediate Similarity NPD1241 Discontinued
0.702 Intermediate Similarity NPD6273 Approved
0.7 Intermediate Similarity NPD6799 Approved
0.698 Remote Similarity NPD2354 Approved
0.698 Remote Similarity NPD3887 Approved
0.6978 Remote Similarity NPD1203 Approved
0.6978 Remote Similarity NPD6362 Approved
0.6972 Remote Similarity NPD2313 Discontinued
0.6972 Remote Similarity NPD3268 Approved
0.697 Remote Similarity NPD690 Clinical (unspecified phase)
0.6953 Remote Similarity NPD1358 Approved
0.6947 Remote Similarity NPD7843 Approved
0.6944 Remote Similarity NPD447 Suspended
0.694 Remote Similarity NPD9092 Discovery
0.6939 Remote Similarity NPD6004 Phase 3
0.6939 Remote Similarity NPD6002 Phase 3
0.6939 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6939 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6939 Remote Similarity NPD6005 Phase 3
0.6934 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6929 Remote Similarity NPD1019 Discontinued
0.6918 Remote Similarity NPD4308 Phase 3
0.6913 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6913 Remote Similarity NPD4110 Phase 3
0.6909 Remote Similarity NPD6765 Approved
0.6909 Remote Similarity NPD6764 Approved
0.6905 Remote Similarity NPD8434 Phase 2
0.6899 Remote Similarity NPD7075 Discontinued
0.6899 Remote Similarity NPD2684 Approved
0.6892 Remote Similarity NPD5958 Discontinued
0.6889 Remote Similarity NPD1894 Discontinued
0.6889 Remote Similarity NPD9545 Approved
0.6887 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6884 Remote Similarity NPD1608 Approved
0.6879 Remote Similarity NPD9494 Approved
0.6875 Remote Similarity NPD3134 Approved
0.6871 Remote Similarity NPD1551 Phase 2
0.6863 Remote Similarity NPD5403 Approved
0.6853 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6849 Remote Similarity NPD7097 Phase 1
0.6846 Remote Similarity NPD2067 Discontinued
0.6842 Remote Similarity NPD5401 Approved
0.6839 Remote Similarity NPD6599 Discontinued
0.6828 Remote Similarity NPD1933 Approved
0.6824 Remote Similarity NPD2344 Approved
0.6821 Remote Similarity NPD7440 Discontinued
0.6809 Remote Similarity NPD2798 Approved
0.6807 Remote Similarity NPD6559 Discontinued
0.6797 Remote Similarity NPD5049 Phase 3
0.6791 Remote Similarity NPD7157 Approved
0.6783 Remote Similarity NPD7095 Approved
0.6779 Remote Similarity NPD4534 Discontinued
0.6774 Remote Similarity NPD7458 Discontinued
0.6774 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6759 Remote Similarity NPD4307 Phase 2
0.6757 Remote Similarity NPD2935 Discontinued
0.6757 Remote Similarity NPD2240 Approved
0.6757 Remote Similarity NPD2239 Approved
0.6753 Remote Similarity NPD920 Approved
0.6752 Remote Similarity NPD6801 Discontinued
0.6746 Remote Similarity NPD6785 Approved
0.6746 Remote Similarity NPD6784 Approved
0.6741 Remote Similarity NPD9493 Approved
0.6739 Remote Similarity NPD3496 Discontinued
0.6738 Remote Similarity NPD3267 Approved
0.6738 Remote Similarity NPD3266 Approved
0.6738 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6736 Remote Similarity NPD411 Approved
0.6732 Remote Similarity NPD4662 Approved
0.6732 Remote Similarity NPD4661 Approved
0.6712 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6711 Remote Similarity NPD2346 Discontinued
0.6711 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6711 Remote Similarity NPD643 Clinical (unspecified phase)
0.6711 Remote Similarity NPD5763 Approved
0.6711 Remote Similarity NPD5762 Approved
0.6711 Remote Similarity NPD2353 Approved
0.6692 Remote Similarity NPD290 Approved
0.669 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6689 Remote Similarity NPD7033 Discontinued
0.6667 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1778 Approved
0.6667 Remote Similarity NPD1876 Approved
0.6667 Remote Similarity NPD17 Approved
0.6646 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6646 Remote Similarity NPD919 Approved
0.6645 Remote Similarity NPD2309 Approved
0.6644 Remote Similarity NPD4060 Phase 1
0.6643 Remote Similarity NPD1481 Phase 2
0.6643 Remote Similarity NPD3972 Approved
0.6641 Remote Similarity NPD2182 Approved
0.6625 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6623 Remote Similarity NPD642 Clinical (unspecified phase)
0.6621 Remote Similarity NPD3764 Approved
0.6619 Remote Similarity NPD3847 Discontinued
0.6604 Remote Similarity NPD7819 Suspended
0.6604 Remote Similarity NPD1006 Clinical (unspecified phase)
0.6597 Remote Similarity NPD2614 Approved
0.6594 Remote Similarity NPD5585 Approved
0.6582 Remote Similarity NPD6677 Suspended
0.6582 Remote Similarity NPD7411 Suspended
0.6579 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6579 Remote Similarity NPD7003 Approved
0.6579 Remote Similarity NPD3750 Approved
0.6571 Remote Similarity NPD1535 Discovery
0.6567 Remote Similarity NPD5535 Approved
0.6564 Remote Similarity NPD8127 Discontinued
0.6562 Remote Similarity NPD5402 Approved
0.6556 Remote Similarity NPD2424 Discontinued
0.6556 Remote Similarity NPD1549 Phase 2
0.6549 Remote Similarity NPD1283 Approved
0.6545 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6533 Remote Similarity NPD2438 Suspended
0.6533 Remote Similarity NPD4476 Approved
0.6533 Remote Similarity NPD1501 Clinical (unspecified phase)
0.6533 Remote Similarity NPD6032 Approved
0.6533 Remote Similarity NPD2796 Approved
0.6533 Remote Similarity NPD4477 Approved
0.6531 Remote Similarity NPD3140 Approved
0.6531 Remote Similarity NPD3142 Approved
0.6528 Remote Similarity NPD454 Approved
0.6522 Remote Similarity NPD7768 Phase 2
0.6522 Remote Similarity NPD3882 Suspended
0.6516 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6513 Remote Similarity NPD1243 Approved
0.6503 Remote Similarity NPD987 Approved
0.6493 Remote Similarity NPD969 Suspended
0.649 Remote Similarity NPD1552 Clinical (unspecified phase)
0.649 Remote Similarity NPD1471 Phase 3
0.649 Remote Similarity NPD1550 Clinical (unspecified phase)
0.649 Remote Similarity NPD6800 Clinical (unspecified phase)
0.6486 Remote Similarity NPD4618 Approved
0.6486 Remote Similarity NPD4622 Approved
0.6481 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6478 Remote Similarity NPD958 Approved
0.6471 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6471 Remote Similarity NPD2629 Approved
0.6467 Remote Similarity NPD3748 Approved
0.6463 Remote Similarity NPD8032 Phase 2
0.646 Remote Similarity NPD3817 Phase 2
0.646 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6456 Remote Similarity NPD2651 Approved
0.6456 Remote Similarity NPD2649 Approved
0.6447 Remote Similarity NPD2897 Discontinued
0.6447 Remote Similarity NPD7596 Clinical (unspecified phase)
0.6438 Remote Similarity NPD1934 Approved
0.6438 Remote Similarity NPD2598 Clinical (unspecified phase)
0.6434 Remote Similarity NPD3225 Approved
0.6433 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6424 Remote Similarity NPD6808 Phase 2
0.6424 Remote Similarity NPD5712 Approved
0.6419 Remote Similarity NPD4140 Approved
0.6419 Remote Similarity NPD2979 Phase 3
0.6415 Remote Similarity NPD4380 Phase 2
0.6412 Remote Similarity NPD9697 Approved
0.6406 Remote Similarity NPD1238 Approved
0.6405 Remote Similarity NPD2976 Clinical (unspecified phase)
0.64 Remote Similarity NPD5688 Approved
0.64 Remote Similarity NPD5689 Approved
0.6398 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6398 Remote Similarity NPD8455 Phase 2
0.6391 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6387 Remote Similarity NPD6652 Clinical (unspecified phase)
0.6385 Remote Similarity NPD6647 Phase 2
0.638 Remote Similarity NPD8005 Clinical (unspecified phase)
0.638 Remote Similarity NPD3749 Approved
0.6376 Remote Similarity NPD230 Phase 1
0.6376 Remote Similarity NPD4340 Discontinued
0.6369 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6369 Remote Similarity NPD2163 Approved
0.6369 Remote Similarity NPD3818 Discontinued
0.6364 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6364 Remote Similarity NPD4359 Approved
0.6364 Remote Similarity NPD8166 Discontinued
0.6364 Remote Similarity NPD3685 Discontinued
0.6364 Remote Similarity NPD7199 Phase 2
0.6358 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6357 Remote Similarity NPD5691 Approved
0.6352 Remote Similarity NPD3455 Phase 2
0.6352 Remote Similarity NPD3226 Approved
0.6341 Remote Similarity NPD6315 Phase 2
0.634 Remote Similarity NPD970 Clinical (unspecified phase)
0.6338 Remote Similarity NPD1281 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data